Search JFSF


JFSF Vol 7, No 4, December 2022, p.257

doi: 10.22540/JFSF-07-257

PDF  


Corrigendum

Corrigendum to: Sarcopenia in Hemiplegia

Maria C. Papadatou1,2

  1. National Center of Rehabilitation, Athens, Greece
  2. National Kapodistrian University of Athens, Laboratory Research of Musculoskeletal Disorders, Greece

Abstract

The author regrets the originally published manuscript Sarcopenia in Hemiplegia, JFSF Vol 5, No 2, June 2020, p.38-41, contained an error in the “Therapeutic approach and management” section. Specifically, instead of selective androgen receptor modulators (SARMs), mistakenly it is written selective estrogen receptor modulators (SERMs).

This article corrects the following

Sarcopenia in Hemiplegia, JFSF, Vol 5, No 2, June 2020, p.38-41


Share this article on:
Twitter  LinkedIn  Facebook